Philip J. Ebeling became Vice President, Chief Technology Officer at St. Jude Medical in January 2016. He leads R&D, regulatory and program management functions across the company. Mr. Ebeling joined St. Jude Medical in 2008 as Vice President, Research and Development, cardiovascular. In 2012, he assumed additional responsibility for electrophysiology R&D.
Prior to joining St. Jude Medical, Mr. Ebeling spent 12 years at Boston Scientific (SciMed), where he was Director, Program Management, and Director, Process Development. He also spent six years as a new product development engineer for Rexam Flexible Packaging. Mr. Ebeling holds five issued or pending patents on medical device design and technology.
He earned a B.S. degree in chemical engineering from the University of Minnesota and an M.B.A. from the University of St. Thomas. Mr. Ebeling has also completed the Advanced Management Program at Harvard Business School in 2013.
